Growth Metrics

Resmed (RMD) Gross Profit (2016 - 2025)

Resmed's Gross Profit history spans 17 years, with the latest figure at $878.7 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 16.96% year-over-year to $878.7 million; the TTM value through Dec 2025 reached $3.3 billion, up 14.22%, while the annual FY2025 figure was $3.1 billion, 15.05% up from the prior year.
  • Gross Profit reached $878.7 million in Q4 2025 per RMD's latest filing, up from $820.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $878.7 million in Q4 2025 to a low of $447.3 million in Q1 2021.
  • Average Gross Profit over 5 years is $636.4 million, with a median of $617.6 million recorded in 2023.
  • Peak YoY movement for Gross Profit: dropped 0.53% in 2021, then grew 25.76% in 2023.
  • A 5-year view of Gross Profit shows it stood at $504.3 million in 2021, then grew by 14.95% to $579.7 million in 2022, then increased by 11.6% to $646.9 million in 2023, then rose by 16.13% to $751.3 million in 2024, then rose by 16.96% to $878.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Gross Profit are $878.7 million (Q4 2025), $820.8 million (Q3 2025), and $820.1 million (Q2 2025).